2016 VAM: 3304 - Emerging and Current Diagnostics and Therapies for Eosinophilic Esophagitis
This session will provide updates regarding clinical approaches and new research in management of eosinophilic esophagitis.
AMA PRA Category 1 Credits™: 1.25
CE: 1.25
Credit must be claimed by May 31, 2018. Any credit request on or after June 1, 2018 will be subject to an administrative fee.
Target Audience
Physicians
Allergists/Immunologists
Nurses
Nurse Practitioners
Allied Health Professionals
Learning Objectives
Upon completion of this activity, participants will be able to:
1. Discuss current and emerging therapies as well as biomarkers in patients with EOE
Additional Information
Attachment | Size |
---|---|
2016 Annual Meeting Disclosures | 120.13 KB |
Amal H. Assa'ad, MD FAAAAI, Children's Hospital Medical Center, Cincinnati, OH
Dr. Gisoo Ghaffari, MD FAAAAI, Penn State Hershey Medical Center, Hershey, PA
Dr. Douglas R. McDonald, MD PhD, Boston Children's Hospital, Boston, MA
Available Credit
- 1.25 AttendanceAttendance credit.
- 1.25 CECE credit.
- 1.25 CMECME credit.